Shots: ADCs, cell therapies, and radioligand therapies are reshaping oncology, while biopharma companies focus on smarter trials, patient-first approaches, and faster access to bridge unmet needs in cancer care In 2024, the global oncology market was valued at $225.01B and is projected to reach $668.26B by 2034, reflecting a strong CAGR of 11.5% from 2025…
Conventional medicine plays a crucial role in diagnosing, treating, and managing diseases through evidence-based interventions, including medications, surgeries, and other standardized treatments. However, there is a growing interest in integrative medicine, which combines conventional treatments with scientifically backed complementary therapies. This shift reflects a broader movement toward patient-centered, holistic healthcare that prioritizes both symptom relief…

